EDEN PRAIRIE, Minn., March 11, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today ...

Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with ...

Vascular access is the most commonly performed invasive procedure in medicine, with 200 million peripheral intravenous (PIV) catheters placed annually in U.S. hospitals to administer fluids, ...

Central venous catheters are frequently used in leukapheresis to provide high flow rates. The most common locations are the subclavian or jugular vein, but insertion-related complications and ...

The peripheral vascular access device segment is expected to register the highest CAGR of 7.6% during the forecast period. The intravenous route of insertion segment is expected to register the ...

EDEN PRAIRIE, Minn., Jan. 12, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced ...

Global Peripheral Venous Access Device Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 is the recent market research report published by MarketsandResearch.biz. The ...

Based on type, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous vascular access device, and accessories. Among these, in ...

Peripheral intervention using the more challenging antegrade route results in a higher rate of access site complications including transfusion than does conventional retrograde access, according to a ...